Expanding the Role of Prescription Drug Monitoring Programs

This Viewpoint proposes an expansion of state-run prescription-drug monitoring programs to meet the need for broader pharmacovigilance given the shift to alternative payment methods that bypass traditional insurance claims.

Corresponding Author: Ashlee N. Mattingly, PharmD, MPH, BCPS, Department of Pharmacotherapy, University of Utah College of Pharmacy, 282 2000 E, Salt Lake City, UT 84112 (ashlee.mattingly@pharm.utah.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.